Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia.
CD14
CD16
chronic myelomonocytic leukemia
classical monocyte
flow cytometry
flowSOM
monocyte
Journal
Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
03
11
2022
received:
19
08
2022
accepted:
21
11
2022
medline:
21
8
2023
pubmed:
1
12
2022
entrez:
30
11
2022
Statut:
ppublish
Résumé
The presence of >94% classical monocytes (MO1, CD14++/CD16-) in peripheral blood (PB) has an excellent performance for the diagnosis of chronic myelomonocytic leukemia (CMML). However, the monocyte gating strategy is not well defined. The objective of the study was to compare monocyte gating strategies and propose an optimal one. This is a prospective, single center study assessing monocyte subsets in PB. First, we compared monocyte subsets using 13 monocyte gating strategies in 10 samples. Then we developed our own 10 color tube and tested it on 124 patients (normal white blood cell counts, reactive monocytosis, CMML and a spectrum of other myeloid malignancies). Both conventional and computational (FlowSOM) analyses were used. Comparing different monocyte gating strategies, small but significant differences in %MO1 and percentually large differences in %MO3 (nonclassical monocytes) were found, suggesting that the monocyte gating strategy can impact monocyte subset quantification. Then, we designed a 10-color tube for this purpose (CD45/CD33/CD14/CD16/CD64/CD86/CD300/CD2/CD66c/CD56) and applied it to 124 patients. This tube allowed proper monocyte gating even in highly abnormal PB. Computational analysis found a higher %MO1 and lower %MO3 compared to conventional analysis. However, differences between conventional and computational analysis in both MO1 and MO3 were globally consistent and only minimal differences were observed when comparing the ranking of patients according to %MO1 or %MO3 obtained with the conventional versus the computational approach. The choice of monocyte gating strategy appears relevant for the monocyte subset distribution test. Our 10-color proposal allowed satisfactory monocyte gating even in highly abnormal PB. Computational analysis seems promising to increase reproducibility in monocyte subset quantification.
Sections du résumé
BACKGROUND
The presence of >94% classical monocytes (MO1, CD14++/CD16-) in peripheral blood (PB) has an excellent performance for the diagnosis of chronic myelomonocytic leukemia (CMML). However, the monocyte gating strategy is not well defined. The objective of the study was to compare monocyte gating strategies and propose an optimal one.
METHODS
This is a prospective, single center study assessing monocyte subsets in PB. First, we compared monocyte subsets using 13 monocyte gating strategies in 10 samples. Then we developed our own 10 color tube and tested it on 124 patients (normal white blood cell counts, reactive monocytosis, CMML and a spectrum of other myeloid malignancies). Both conventional and computational (FlowSOM) analyses were used.
RESULTS
Comparing different monocyte gating strategies, small but significant differences in %MO1 and percentually large differences in %MO3 (nonclassical monocytes) were found, suggesting that the monocyte gating strategy can impact monocyte subset quantification. Then, we designed a 10-color tube for this purpose (CD45/CD33/CD14/CD16/CD64/CD86/CD300/CD2/CD66c/CD56) and applied it to 124 patients. This tube allowed proper monocyte gating even in highly abnormal PB. Computational analysis found a higher %MO1 and lower %MO3 compared to conventional analysis. However, differences between conventional and computational analysis in both MO1 and MO3 were globally consistent and only minimal differences were observed when comparing the ranking of patients according to %MO1 or %MO3 obtained with the conventional versus the computational approach.
CONCLUSIONS
The choice of monocyte gating strategy appears relevant for the monocyte subset distribution test. Our 10-color proposal allowed satisfactory monocyte gating even in highly abnormal PB. Computational analysis seems promising to increase reproducibility in monocyte subset quantification.
Identifiants
pubmed: 36448679
doi: 10.1002/cyto.b.22106
doi:
Substances chimiques
Receptors, IgG
0
Lipopolysaccharide Receptors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
319-330Informations de copyright
© 2022 International Clinical Cytometry Society.
Références
Alhan, C., Westers, T. M., Cremers, E. M. P., Cali, C., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2016). Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations. Cytometry Part B: Clinical Cytometry, 90, 358-367.
Allen, S. A., Ng, E., Hahn, U. H., Banovic, T., & Ross, D. M. (2022). Flow cytometric monocyte repartition demonstrates overlap between chronic myelomonocytic leukaemia and myeloid neoplasms with monocytosis. Pathology, 54, 953-955.
Brinkman, R. R. (2020). Improving the rigor and reproducibility of flow cytometry-based clinical research and trials through automated data analysis. Cytometry Part A, 97, 107-112.
Calvo, X., Garcia-Gisbert, N., Parraga, I., Gibert, J., Florensa, L., Andrade-Campos, M., Merchan, B., Garcia-Avila, S., Montesdeoca, S., Fernández-Rodríguez, C., Salido, M., Puiggros, A., Espinet, B., Colomo, L., Roman-Bravo, D., Bellosillo, B., Ferrer, A., & Arenillas, L. (2020). Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features. Blood Advances, 4, 5285-5296.
Cusinato, M., Hadcocks, L., Yona, S., Planche, T., & Macallan, D. (2022). Increased monocyte distribution width in <scp>COVID</scp> -19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency. International Journal of Laboratory Hematology, 44, 1029-1039.
Duetz, C., Bachas, C., Westers, T. M., & Van De Loosdrecht, A. A. (2020). Computational analysis of flow cytometry data in hematological malignancies: Future clinical practice? Current Opinion in Oncology, 32, 162-169.
Duetz, C., van Gassen, S., Westers, T. M., Spronsen, M. F., Bachas, C., Saeys, Y., & van de Loosdrecht, A. A. (2021). Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes. Cytometry Part A, 99, 814-824.
Eckel, A. M., Cherian, S., Miller, V., & Soma, L. (2020). CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry. Cytometry Part B: Clinical Cytometry, 98, 174-178.
Gatti, A., Radrizzani, D., Viganò, P., Mazzone, A., & Brando, B. (2020). Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection. Cytometry Part A, 97, 887-890.
Hayes, D. F. (2021). Defining clinical utility of tumor biomarker tests: A clinician's viewpoint. Journal of Clinical Oncology, 39, 238-248.
Heimbeck, I., Hofer, T. P. J., Eder, C., Wright, A. K., Frankenberger, M., Marei, A., Boghdadi, G., Scherberich, J., & Ziegler-Heitbrock, L. (2010). Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females. Cytometry Part A, 77A, 823-830.
Hill, A. J., Zhang, C., Kusakabe, M., Gowing, K., Wang, X., Brinkman, R. R., Weng, A. P., & Craig, J. W. (2021). Occurrence of T-cell and NK-cell subsets with less well-recognized phenotypes in peripheral blood submitted for routine flow cytometry analysis. Cytometry Part B: Clinical Cytometry, 100, 235-239.
Hudson, C. A., Burack, W. R., Leary, P. C., & Bennett, J. M. (2018). Clinical utility of classical and nonclassical monocyte percentage in the diagnosis of chronic myelomonocytic leukemia. American Journal of Clinical Pathology, 150, 293-302.
Jestin, M., Tarfi, S., Duchmann, M., Badaoui, B., Freynet, N., Tran Quang, V., Sloma, I., Droin, N., Morabito, M., Leclerc, M., Maury, S., Fenaux, P., Solary, E., Selimoglu-Buet, D., Wagner-Ballon, O., & Groupe Francophone des Myélodysplasies (GFM). (2021). Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: Results of a multicenter study. Leukemia, 35, 893-896.
Johansson, U., McIver-Brown, N., Cullen, M., Duetz, C., Dunlop, A., Oelschlägel, U., Psarra, K., Subirá, D., & Westers, T. M. (2021). The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22048
Korevaar, D. A., Toubiana, J., Chalumeau, M., McInnes, M. D. F., & Cohen, J. F. (2021). Evaluating tests for diagnosing COVID-19 in the absence of a reliable reference standard: Pitfalls and potential solutions. Journal of Clinical Epidemiology, 138, 182-188.
Lacombe, F., Lechevalier, N., Vial, J. P., & Béné, M. C. (2019). An R-derived FlowSOM process to analyze unsupervised clustering of normal and malignant human bone marrow classical flow cytometry data. Cytometry Part A, 95, 1191-1197.
Maecker, H. T., Rinfret, A., D'Souza, P., Darden, J., Roig, E., Landry, C., Hayes, P., Birungi, J., Anzala, O., Garcia, M., Harari, A., Frank, I., Baydo, R., Baker, M., Holbrook, J., Ottinger, J., Lamoreaux, L., Epling, C. L., Sinclair, E., … Suni, M. A. (2005). Standardization of cytokine flow cytometry assays. BMC Immunology, 6, 13.
Mair, F., & Liechti, T. (2021). Comprehensive phenotyping of human dendritic cells and monocytes. Cytometry Part A, 99, 231-242.
Murali, A., Cross, D., & Mollee, P. (2021). The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia. Blood Cancer Journal, 11, 6.
Park, L. M., Lannigan, J., & Jaimes, M. C. (2020). OMIP-069: Forty-color full spectrum flow cytometry panel for deep immunophenotyping of major cell subsets in human peripheral blood. Cytometry Part A, 97, 1044-1051.
Pophali, P. A., Timm, M. M., Mangaonkar, A. A., Shi, M., Reichard, K., Tefferi, A., Pavelko, K., Villasboas, J. C., Jevremovic, D., & Patnaik, M. M. (2019). Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia. Blood Cancer Journal, 9, 65.
Quintelier, K., Couckuyt, A., Emmaneel, A., Aerts, J., Saeys, Y., & Van Gassen, S. (2021). Analyzing high-dimensional cytometry data using FlowSOM. Nature Protocols, 16, 3775-3801.
Rutjes, A. W., Reitsma, J. B., Coomarasamy, A., Khan, K. S., & Bossuyt, P. M. (2007). Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health technology assessment (Winchester, England), 11(50), iii-51.
Selimoglu-Buet, D., Badaoui, B., Benayoun, E., Toma, A., Fenaux, P., Quesnel, B., Etienne, G., Braun, T., Abermil, N., Morabito, M., Droin, N., Solary, E., Wagner-Ballon, O., & Groupe Francophone des Myélodysplasies. (2017). Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML. Blood, 130, 832-835.
Selimoglu-Buet, D., Wagner-Ballon, O., Saada, V., Bardet, V., Itzykson, R., Bencheikh, L., Morabito, M., Met, E., Debord, C., Benayoun, E., Nloga, A. M., Fenaux, P., Braun, T., Willekens, C., Quesnel, B., Adès, L., Fontenay, M., Rameau, P., Droin, N., … Solary, E. (2015). Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood, 125, 3618-3626.
Shikuma, C. M., Chow, D. C., Gangcuangco, L. M. A., Zhang, G., Keating, S. M., Norris, P. J., Seto, T. B., Parikh, N., Kallianpur, K. J., Nakamoto, B. K., Nagamine, L. S., Ndhlovu, L. C., & Barbour, J. D. (2014). Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV. PLoS One, 9, e90330.
Soh, K. T., Tario, J. D., Hahn, T. E., Hillengass, J., McCarthy, P. L., & Wallace, P. K. (2020). Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease. Cytometry Part B: Clinical Cytometry, 98, 161-173.
Soh, K. T., & Wallace, P. K. (2021). Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications. International Journal of Laboratory Hematology, 43, 43-53.
Sommer, U., Eck, S., Marszalek, L., Stewart, J. J., Bradford, J., McCloskey, T. W., Green, C., Vitaliti, A., Oldaker, T., & Litwin, V. (2021). High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of rare events. Cytometry Part B: Clinical Cytometry, 100, 42-51.
Staats, J., Divekar, A., McCoy, J. P., & Maecker, H. T. (2019). Guidelines for gating flow cytometry data for immunological assays. Methods in Molecular Biology, 2032, 81-104.
Staser, K. W., Eades, W., Choi, J., Karpova, D., & DiPersio, J. F. (2018). OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood. Cytometry Part A, 93, 186-189.
Tarfi, S., Badaoui, B., Freynet, N., Morabito, M., Lafosse, J., Toma, A., Etienne, G., Micol, J. B., Sloma, I., Fenaux, P., Solary, E., Selimoglu-Buet, D., Wagner-Ballon, O., & Groupe Francophone des Myelodysplasies (GFM). (2020). Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state. Haematologica, 105, e147-e152.
Tarfi, S., Harrivel, V., Dumezy, F., Guy, J., Roussel, M., Mimoun, A., Fenaux, P., Chapuis, N., Solary, E., Selimoglu-Buet, D., & Wagner-Ballon, O. (2018). Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis. Blood Cancer Journal, 8, 1-10.
Thomas, G. D., Hamers, A. A. J., Nakao, C., Marcovecchio, P., Taylor, A. M., McSkimming, C., Nguyen, A. T., McNamara, C. A., & Hedrick, C. C. (2017). Human blood monocyte subsets. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1548-1558.
Van Der Maaten, L., & Hinton, G. (2008). Visualizing data using t-sne. Journal of Machine Learning Research, 9, 2579-2605.
Van Gassen, S., Callebaut, B., Van Helden, M. J., Lambrecht, B. N., Demeester, P., Dhaene, T., & Saeys, Y. (2015). FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytometry Part A, 87, 636-645.
Velden, V. H. J., Preijers, F., Johansson, U., Westers, T. M., Dunlop, A., Porwit, A., Béné, M. C., Valent, P., Marvelde, J., Wagner-Ballon, O., Oelschlaegel, U., Saft, L., Kordasti, S., Ireland, R., Cremers, E., Alhan, C., Duetz, C., Hobo, W., Chapuis, N., … Fontenay, M. (2021). Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22046
Velegraki, M., Papakonstantinou, N., Kalaitzaki, L., Ntoufa, S., Laidou, S., Tsagiopoulou, M., Bizymi, N., Damianaki, A., Mavroudi, I., Pontikoglou, C., & Papadaki, H. A. (2021). Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome. Blood Cells, Molecules & Diseases, 86, 102507.
Vial, J. P., Lechevalier, N., Lacombe, F., Dumas, P.-Y., Bidet, A., Leguay, T., Vergez, F., Pigneux, A., & Béné, M. C. (2021). Unsupervised flow cytometry analysis allows for an accurate identification of minimal residual disease assessment in acute myeloid leukemia. Cancers (Basel), 13, 629.
Wagner-Ballon, O., Bettelheim, P., Lauf, J., Bellos, F., Della Porta, M., Travaglino, E., Subira, D., Lopez, I. N., Tarfi, S., Westers, T. M., Johansson, U., Psarra, K., Karathanos, S., Matarraz, S., Colado, E., Gupta, M., Ireland, R., Kern, W., van de Loosdrecht, A. A., & European LeukemiaNet International MDS-Flow Cytometry Working Group (ELN iMDS-Flow). (2021). ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22054
Westera, L., van Viegen, T., Jeyarajah, J., Azad, A., Bilsborough, J., van den Brink, G. R., Cremer, J., Danese, S., D'Haens, G., Eckmann, L., Faubion, W., Filice, M., Korf, H., McGovern, D., Panes, J., Salas, A., Sandborn, W. J., Silverberg, M. S., Smith, M. I., … Vermeire, S. (2017). Centrally determined standardization of flow cytometry methods reduces Interlaboratory variation in a prospective multicenter study. Clinical and Translational Gastroenterology, 8, e126.
Zawada, A. M., Fell, L. H., Untersteller, K., Seiler, S., Rogacev, K. S., Fliser, D., Ziegler-Heitbrock, L., & Heine, G. H. (2015). Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study. Cytometry Part A, 87, 750-758.
Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J. M., Liu, Y. J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K., Sozzani, S., Strobl, H., Zembala, M., Austyn, J. M., & Lutz, M. B. (2010). Nomenclature of monocytes and dendritic cells in blood. Blood, 116, e74-e80.